(Q40470636)

20 September 2017

title

Nephrotoxicity with cyclooxygenase 2 inhibitor use in children. (English)

1 reference

20 September 2017

Jeffery T Fletcher

1

1 reference

20 September 2017

Nicole Graf

2

1 reference

20 September 2017

Anthony Scarman

3

1 reference

20 September 2017

Hamda Saleh

4

1 reference

20 September 2017

Stephen I Alexander

5

1 reference

20 September 2017

publication date

6 September 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

21

1 reference

20 September 2017

issue

12

1 reference

20 September 2017

page(s)

1893-1897

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-006-0252-x

20 September 2017

exact match

0 references

cites work

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-006-0252-X

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

12 December 2020

Pediatric clinical trial experience: government, child, parent and physician's perspective

1 reference

12 December 2020

Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome

1 reference

12 December 2020

Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.

1 reference

12 December 2020

Ibuprofen and acute renal failure in a toddler

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

12 December 2020

Acute renal dysfunction associated with selective COX-2 inhibitor therapy

1 reference

12 December 2020

Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice

1 reference

12 December 2020

Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter???s syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib

1 reference

12 December 2020

Clinical trials in children.

1 reference

12 December 2020

FDA labors over NSAID decisions: panel suggests COX-2 inhibitors stay available

1 reference

12 December 2020

COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature.

1 reference

12 December 2020

Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib

1 reference

12 December 2020

A unique complication of nonsteroidal anti-inflammatory drug use.

1 reference

12 December 2020

A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database

1 reference

12 December 2020

Analgesic nephropathy in the 1990s--an Australian perspective.

1 reference

12 December 2020

Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs

1 reference

12 December 2020

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

12 December 2020

Bartter syndrome: benefits and side effects of long-term treatment

1 reference

12 December 2020

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

10.1007/S00467-006-0252-X

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1043843659

0 references

1 reference